Clinical Trials Logo

Takotsubo Cardiomyopathy clinical trials

View clinical trials related to Takotsubo Cardiomyopathy.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05768542 Completed - Clinical trials for Takotsubo Cardiomyopathy

Sympathetic and Vascular Function in Takotsubo Syndrome

SAFT
Start date: April 12, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this prospective, observational study is to compare muscle sympathetic nerve activity at rest and during stress between female patients with Takotsubo syndrome and healthy, matched volunteers. - Do Takotsubo patients have an increased sympathetic nerve activity compared to controls? - Do Takotsubo patients have an exaggerated sympathetic nerve activity response to stress? - Does the sympathetic nerve activity response to stress in Takotsubo change after receiving the beta blocking agent metoprolol? Participants will be examined with muscle sympathetic nerve activity recording in the peroneal nerve at rest and during cold pressor test. After intravenous injection with beta blocking agent (metoprolol) or placebo (saline) in a 1:1 randomized fashion, muscle sympathetic nerve recording at rest and during stress will be repeated.

NCT ID: NCT05530135 Completed - Clinical trials for Takotsubo Cardiomyopathy

Life-style Interventions for Modulating the Brain Phenotype of Takotsubo Cardiomyopathy

BREAKOUT
Start date: October 6, 2020
Phase: N/A
Study type: Interventional

Takotsubo cardiomyopathy presents like a heart attack and is typically triggered by intense emotional or physical stress. Recovery of this condition varies and many patients continue to suffer from symptoms such as fatigue and breathlessness for a protracted period after their event. The purpose of this study is to establish whether following a structured exercise program or a mental wellbeing program compared to usual care for 12 weeks after an episode of Takotsubo will result in significant improvement in the brain activity, general and mental wellbeing of patients.

NCT ID: NCT04684004 Completed - Clinical trials for Takotsubo Cardiomyopathy

Hyperglycemia in Patients With Takotsubo Syndrome

Start date: January 1, 2013
Phase:
Study type: Observational

Patients with Takotsubo cardiomiopathy (TTC) have over-inflammation and over-sympathetic tone. However, these conditions could cause higher rate of heart failure (HF) events and deaths at 2 years of follow-up. Conversely, hyperglycemia vs. normoglycemia could result in over expression of inflammatory markers and catecholamines thta could result in higher rate of HF and deaths at 2 years of follow-up in TTC patients.

NCT ID: NCT04425785 Completed - Clinical trials for Takotsubo Cardiomyopathy

Physical Exercise and Mental Wellbeing Rehabilitation for Acute Stress-induced Takotsubo Cardiomyopathy: The PLEASE Study

PLEASE
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Takotsubo cardiomyopathy presents like a heart attack and is typically triggered by intense emotional or physical stress. Recovery of this condition varies and many patients continue to suffer from symptoms such as fatigue and breathlessness for a protracted period after their event. Research conducted in our unit has found that the heart function does not recover fully as is commonly believed and that the energetic status of the heart remains impaired for an extended period of time. The purpose of our study is to establish whether following a structured exercise program or a mental wellbeing program compared to usual care for 12 weeks after an episode of Takotsubo will improve the energy status of the heart, their physical conditioning and improve the general mental wellbeing of patients.

NCT ID: NCT03801694 Completed - Clinical trials for Acute Ischemic Stroke

Predicting the Development of Myocardial Depression in Acute Neurological Patients

Start date: December 3, 2018
Phase:
Study type: Observational

The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.

NCT ID: NCT03787810 Completed - Clinical trials for Acute Coronary Syndrome

Left Ventricular Dysfunction in Critically Ill Patients

LEVEDYCIP
Start date: May 28, 2018
Phase:
Study type: Observational

Left ventricular dysfunction is common in the critically ill. The aim of this study is to assess the incidence and prognosis of left ventricular dysfunction in critically ill patients.

NCT ID: NCT03761654 Completed - Clinical trials for Left Ventricular Dysfunction

Detection of Myocardial Dysfunction in Non-severe Subarachnoid Hemorrhage (WFNS 1-2) Using Speckle-tracking Echocardiography (STRAIN)

SAH-STRAIN
Start date: January 2, 2019
Phase:
Study type: Observational

Subarachnoid hemorrhage (SAH) can cause transient myocardial dysfunction. Recently, it have been reported that myocardial dysfunctions that occur in SAH are associated with poor outcomes. It therefore appears essential to detect theses dysfunctions with the higher sensitivity as possible. Strain measurement using speckle-tracking echocardiography may detect myocardial dysfunction with great sensitivity. The main objective of this study is to assess the prevalence of myocardial dysfunction in "non-severe" SAH (defined by a WFNS grade 1 or 2), using speckle-tracking echocardiography. This study also aims to analyse Strain measurement with classical echocardiography and serum markers (troponin, BNP) of cardiac dysfunction.

NCT ID: NCT03726528 Completed - Takotsubo Syndrome Clinical Trials

Optimized Characterization of Takotsubo Syndrome by Obtaining Pressure Volume Loops

OCTOPUS
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Aim of this prospective study is to assess the pathophysiology of Takotsubo Syndrome by obtaining pressure volume loops with conductance catheters, which allows detailed conclusions regarding systolic and diastolic hemondynamics and subsequently regarding potential underlying mechanisms

NCT ID: NCT02989454 Completed - Clinical trials for Tako-tsubo Cardiomyopathy

Persistent Symptoms and Early Incomplete Recovery After Acute Stress-induced Cardiomyopathy: Is There Ongoing Heart Distress? The HEROIC Study

HEROIC
Start date: August 2015
Phase:
Study type: Observational

Acute stress induced (Tako-tsubo) cardiomyopathy (TTC) or broken heart syndrome, a condition typically occurring after acute stress has a death rate similar to heart attacks and is frequently associated with long-term symptoms (fatigue and exercise limitation). There are no effective therapies. The investigators have recently showed that there is a profound shortage of energy in the hearts of Tako Tsubo Cardiomyopathy patients in the days after acute presentation with only partial recovery by four months. The investigators would now like to establish whether this recovers after at least one year, or persists, and also to investigate the mechanisms responsible for exercise limitation after recovery from the acute phase.

NCT ID: NCT02897739 Completed - Clinical trials for Tako-tsubo Cardiomyopathy

Pathogenesis of Acute Stress Induced (Tako-tsubo) Cardiomyopathy: Energy Shut-Down or Intense Inflammation?

TERRIFIC
Start date: August 2015
Phase:
Study type: Observational [Patient Registry]

Tako Tsubo Cardiomyopathy (TTC), also known as "Broken Heart Syndrome", is a disorder of the heart that occurs most commonly in women (although it occasionally occurs in men) and is usually related to a stressful event. Symptoms are often similar to a heart attack, and include chest pain and shortness of breath. Although Tako Tsubo Cardiomyopathy is not a new medical condition, it has not been widely recognised until the last decade. Currently the investigators don't have an exact understanding of how or why the heart is affected in this way, and so the investigators are conducting a study to help understand what causes Tako Tsubo Cardiomyopathy.